![Hilary Malone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hilary Malone
Director/Board Member at
HANSA BIOPHARMA AB
Profile
Hilary Malone is currently Chief Executive Officer at CorriXR Therapeutics Inc. since 2026, Independent Director at Hansa Biopharma AB since 2021, and Venture Partner at Boston Millennia Partners.
Former roles include Director at Inhibikase Therapeutics, Inc. from 2016 to 2019, Chief Operating Officer & Executive Vice President at Valo Health, Inc. from 2020 to 2021, Chief Regulatory & Compliance Officer at Reata Pharmaceuticals, Inc. from 2011 to 2012, Chief Regulatory Officer & Senior Vice President at Sanofi, Inc., and Chief Operating Officer at Valo Health LLC from 2020 to 2024.
Education includes undergraduate and doctorate degrees from the University of Dundee.
Hilary Malone active positions
| Companies | Position | Start |
|---|---|---|
| HANSA BIOPHARMA AB | Director/Board Member | 2021-05-11 |
Boston Millennia Partners
 Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Private Equity Investor | - |
Corrixr Therapeutics Inc.
 Corrixr Therapeutics Inc. Packaged SoftwareTechnology Services Operates as a biotherapeutics development company that develops novel IP-protected in vivo gene editing therapeutic platform technology | Chief Executive Officer | 2026-06-01 |
Former positions of Hilary Malone
| Companies | Position | End |
|---|---|---|
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Chief Operating Officer | 2024-11-17 |
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Chief Operating Officer | 2021-08-31 |
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 2018-12-31 |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | - |
| REATA PHARMACEUTICALS, INC. | General Counsel | - |
Training of Hilary Malone
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Boston Millennia Partners
Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Finance |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Technology Services |
Corrixr Therapeutics Inc.
Corrixr Therapeutics Inc. Packaged SoftwareTechnology Services Operates as a biotherapeutics development company that develops novel IP-protected in vivo gene editing therapeutic platform technology | Technology Services |
- Stock Market
- Insiders
- Hilary Malone
